BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24029118)

  • 21. Chronic neutrophilic leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management.
    Elliott MA; Tefferi A
    Am J Hematol; 2016 Mar; 91(3):341-9. PubMed ID: 26700908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs).
    Reilly JT
    Leukemia; 2008 Oct; 22(10):1818-27. PubMed ID: 18754027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A CSF3R T618I Mutation in a Patient with Chronic Neutrophilic Leukemia and Severe Bleeding Complications.
    Mitsumori T; Komatsu N; Kirito K
    Intern Med; 2016; 55(4):405-7. PubMed ID: 26875968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of imatinib mesylate (STI571) in chronic neutrophilic leukemia with t(15;19): case report.
    Choi IK; Kim BS; Lee KA; Ryu S; Seo HY; Sul H; Choi JG; Sung HJ; Park KH; Yoon SY; Oh SC; Seo JH; Choi CW; Shin SW; Yoon SY; Cho Y; Kim YK; Kim YH; Kim JS
    Am J Hematol; 2004 Dec; 77(4):366-9. PubMed ID: 15551277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloblastic transformation of chronic neutrophilic leukaemia.
    Amato D; Memon S; Wang C
    Br J Haematol; 2008 Jun; 142(2):148. PubMed ID: 18510688
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ruxolitinib in the treatment of two cases of chronic neutrophilic leukemia].
    Zheng WS; Guan LX; Cheng LC; Hu YL; Xu YY; Yang T; Peng B; Wu YL; Bo J; Wang QS; Gao XN
    Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):113-114. PubMed ID: 32135644
    [No Abstract]   [Full Text] [Related]  

  • 27. Rare presentation of leucocytosis.
    Bhave AA; Rao RG; Patil GT
    J Assoc Physicians India; 2006 Nov; 54():881-2. PubMed ID: 17249258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSF3R is mutated in chronic neutrophilic leukemia and atypical CML.
    Cancer Discov; 2013 Jul; 3(7):OF23. PubMed ID: 23847367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic neutrophilic leukaemia.
    Uppal G; Gong J
    J Clin Pathol; 2015 Sep; 68(9):680-4. PubMed ID: 26082513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha.
    Murphy PT; McPherson S; Langabeer SE
    Ann Hematol; 2011 Feb; 90(2):233-4. PubMed ID: 20512575
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferon alfa therapy in CALR-mutated essential thrombocythemia.
    Cassinat B; Verger E; Kiladjian JJ
    N Engl J Med; 2014 Jul; 371(2):188-9. PubMed ID: 25006741
    [No Abstract]   [Full Text] [Related]  

  • 32. CSF3R T618I, ASXL1 G942 fs and STAT5B N642H trimutation co-contribute to a rare chronic neutrophilic leukaemia manifested by rapidly progressive leucocytosis, severe infections, persistent fever and deep venous thrombosis.
    Luo Q; Shen J; Yang Y; Tang H; Shi M; Liu J; Liu Z; Shi X; Yi Y
    Br J Haematol; 2018 Mar; 180(6):892-894. PubMed ID: 27984641
    [No Abstract]   [Full Text] [Related]  

  • 33. Clonality of chronic neutrophilic leukemia.
    Lugassy G
    Blood; 1994 Jan; 83(2):619. PubMed ID: 8286757
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of chronic neutrophilic leukemia with trisomy 8.
    Orazi A; Cattoretti G; Sozzi G
    Acta Haematol; 1989; 81(3):148-51. PubMed ID: 2496562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasm.
    Eskazan AE; Salihoglu A; Diz-Kucukkaya R; Hancer VS; Soysal T
    Ann Hematol; 2012 Feb; 91(2):305-6. PubMed ID: 21584669
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chronic neutrophilic leukemia associated with myeloma. Simultaneous presentation].
    Diéguez JC; Fernández Jurado A; Amián A; Rodríguez JN; Martino ML; Cañavate M; Prados D
    Sangre (Barc); 1992 Oct; 37(5):403-6. PubMed ID: 1293783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetically informed therapy in leukemia.
    Radich J
    N Engl J Med; 2013 May; 368(19):1838-9. PubMed ID: 23656651
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia.
    Li B; Gale RP; Xiao Z
    J Hematol Oncol; 2014 Dec; 7():93. PubMed ID: 25498990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.
    Elliott MA; Pardanani A; Hanson CA; Lasho TL; Finke CM; Belachew AA; Tefferi A
    Am J Hematol; 2015 Jul; 90(7):653-6. PubMed ID: 25850813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.